Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy ― The HORIZON-HCM Study ―Hiroaki Kitaoka, Chisato Izumi, Masaki Ieda et al.|Circulation Journal|2024Cited by 23
Multicenter investigation of the incidence of inferior vena cava filter fractureJun Koizumi, Kunio Shirato, Masato Tanikake et al.|Japanese Journal of Radiology|2018Cited by 9
Contemporary clinical characteristics and management patterns in hypertrophic cardiomyopathy: insights from baseline enrolment data in a nationwide prospective Japanese registryToru Kubo, Hiroaki Kitaoka, Kenta Sugiura et al.|Heart|2025Cited by 3